Future of geriatric oncology

Aging Health

Volumn 3, Issue 2, 2007, Pages 149-158

  Extermann, Martine ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Elderly; Geriatric oncology

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE;

ARTICLE; B CELL LYMPHOMA; BREAST CANCER; CANCER; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; COLON CANCER; COMBINATION CHEMOTHERAPY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISABILITY; DISEASE FREE SURVIVAL; ELDERLY CARE; FAMILIAL CANCER; FRAIL ELDERLY; FUNCTIONAL STATUS; GENE MAPPING; GERIATRIC ASSESSMENT; HEALTH PROGRAM; HUMAN; LARGE CELL LYMPHOMA; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; MAMMOGRAPHY; MEDICAL SOCIETY; MONOTHERAPY; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; PATIENT ASSESSMENT; PATIENT EDUCATION; PHARMACODYNAMICS; POLYPHARMACY; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE;

EID: 34247256908     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.3.2.149     Document Type: Article

References (59)

1. Yancik R, Carbone PP, National Cancer Institute, National Institute on Aging: Perspective on Prevention and Treatment of Cancer in the Elderly. Raven Press, NY, USA (1983).
2. Begg CB, Carbone PP: Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 52, 1986-1992 (1983).
3. Gelman RS, Taylor SG: Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. J. Clin. Oncol. 2, 1404-1413 (1984).
4. Balducci L, Lyman GH, Ershler WB, Extermann M: Comprehensive Geriatric Oncology (2nd Edition). Taylor and Francis, London, UK and NY, USA (2004).
5. Kennedy B: Cancer Care in the Older Population. Alexandria VA (Ed). American Society of Clinical Oncology, VA, USA (2003).
6. Extermann M, Albrand G, Chen H et al.: Are older French patients as willing as older American patients to undertake chemotherapy? J. Clin. Oncol. 21, 3214-3219 (2003).
7. Audisio RA, Ramesh H, Longo WE, Zbar AP, Pope D: Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 10, 262-268 (2005).
8. Extermann M, Chen H, Cantor AB et al.: Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur. J. Cancer 38, 1466-1473 (2002).
9. Overcash J, Extermann M, Parr J, Perry J, Balducci L: Validity and reliability of the FACT-G scale for use in the older person with cancer. Am. J. Clin. Oncol. 24, 591-596 (2001).
10. Monfardini S, Aversa SM, Zoli V et al.: Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Ann. Oncol. 16, 1352-1358 (2005).
11. Maione P, Perrone F, Gallo C et al.: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J. Clin. Oncol. 23, 6865-6872 (2005).
12. Freyer G, Geay JF, Touzet S et al.: Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann. Oncol. 16, 1795-1800 (2005).
13. Firat S, Bousamra M, Gore E et al.: Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 52, 1047-1057 (2002).
14. Firat S, Byhardt RW, Gore E: Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 54, 357-364 (2002).
15. Callen LJ VP, Overcash J, Boulware D, Extermann M: Survival and Patterns of Care in Older Cancer Patients with Cognitive Impairment. International Society of Geriatric Oncology, CA, USA (2004).
16. Repetto L, Fratino L, Audisio, RA et al.: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J. Clin. Oncol. 20, 494-502 (2002).
17. McCorkle R, Strumpf NE, Nuamah IF et al.: A specialized home care intervention improves survival among older post-surgical cancer patients. J. Am. Geriatr. Soc. 48, 1707-1713 (2000).
18. Extermann M, Meyer J, McGinnis M et al.: A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit. Rev. Oncol. Hematol. 49, 69-75 (2004).
19. Johnson DJ, Balducci L, Extermann M, Crocker T, McGinnis M, Vranas P: The Assessment of Clinical Resources in a Senior Adult Oncology Program. European Oncology Nursing Society Meeting, Innsbruck, Austria (2006) (Abstract).
20. Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van den Berg HA, Coebergh JW: Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit. Rev. Oncol. Hematol. 58, 60-67 (2006).
21. Vulto AJ, Lemmens VE, Louwman MW et al.: The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands 1995 to 2002. Cancer 106, 2734-2742 (2006).
22. Prout GR Jr, Wesley MN, Yancik R et al.: Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104, 1638-1647 (2005).
23. Bouchardy C, Rapiti E, Fioretta G et al.: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J. Clin. Oncol. 21, 3580-3587 (2003).
24. Christman K, Muss HB, Case LD, Stanley V: Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience. JAMA 268, 57-62 (1992).
25. Hurria A, Zuckerman E, Panageas KS et al.: A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J. Am. Geriatr. Soc. 54, 1119-1124 (2006).
26. Chen H, Cantor A, Meyer J et al.: Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 97, 1107-1114 (2003).
27. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N. Engl. J. Med. 341, 2061-2067 (1999).
28. Kemeny MM, Peterson BL, Kornblith AB et al.: Barriers to clinical trial participation by older women with breast cancer. J. Clin. Oncol. 21, 2268-2275 (2003).
29. Kornblith AB, Kemeny M, Peterson BL et al.: Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95, 989-996 (2002).
30. Kimmick G, Kornblith A, Mandelblatt J et al.: A randomized controlled trial of an educational program to improve accrual of older persons to cancer treatment protocols: CALGB 360001. American Society of Clinical Oncology Annual Meeting Proceedings (2004) (Abstract).
31. Lewis JH, Kilgore ML, Goldman DP et al.: Participation of patients 65 years of age or older in cancer clinical trials. J. Clin. Oncol. 21, 1383-1389 (2003).
32. Tirelli U, Errante D, Van Glabbeke M et al.: CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J. Clin. Oncol. 16, 27-34 (1998).
33. Sehn LH, Donaldson J, Chhanabhai M et al.: Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J. Clin. Oncol. 23, 5027-5033 (2005).
34. Balducci L, Lyman GH: Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J. Clin. Oncol. 19, 1583-1585 (2001).
35. Smith TJ, Khatcheressian J, Lyman GH et al.: 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J. Clin. Oncol. 24, 3187-3205 (2006).
36. Gridelli C: The ELVIS trial: a Phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung cancer Vinorelbine Italian Study. Oncologist 6(Suppl. 1), 4-7 (2001).
37. Gridelli C, Perrone F, Gallo C et al.: Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung cancer in the Elderly Study (MILES) Phase III randomized trial. J. Natl Cancer Inst. 95, 362-372 (2003).
38. Frasci G, Lorusso V, Panza N et al.: Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J. Clin. Oncol. 18, 2529-2536 (2000).
39. Jatoi A, Hillman S, Stella P et al.: Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J. Clin. Oncol. 23, 9113-9119 (2005).
40. Castiglione M, Gelber RD, Goldhirsch A: Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group. J. Clin. Oncol. 8, 519-526 (1990).
41. Fargeot P, Bonneterre J, Roche H et al.: Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. J. Clin. Oncol. 22, 4622-4630 (2004).
42. Extermann M. Balducci L. Lyman GH: What threshold for adjuvant therapy in older breast cancer patients? J. Clin. Oncol. 18, 1709-1717 (2000).
43. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD: Do older men benefit from curative therapy of localized prostate cancer? J. Clin. Oncol. 21, 3318-3327 (2003).
44. Mandelblatt J, Yabroff KR, Lawrence W et al.: Screening mammography in elderly women. Research on Breast Cancer in Older Women Consortium. JAMA 283, 3202-3203 (2000).
45. Kerlikowske K. Salzmann P, Phillips KA, Cauley JA, Cummings SR: Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA 282, 2156-2163 (1999).
46. Anisimov VN: The relationship between aging and carcinogenesis: a critical appraisal. Crit. Rev. Oncol. Hematol. 45, 277-304 (2003).
47. Campisi J: Senescent cells, tumor suppression, and organismal aging good citizens, bad neighbors. Cell 120, 513-522 (2005).
48. Ershler WB: The influence of an aging immune system on cancer incidence and progression. J. Gerontol. 48, B3-B7 (1993).
49. Balducci L, Ershler WB: Cancer and ageing: a nexus at several levels. Nat. Rev. Cancer 5, 655-662 (2005).
50. Meyerhardt JA, Catalano PJ, Haller DG et al.: Impact of diabetes mellitus on outcomes in patients with colon cancer. J. Clin. Oncol. 21, 433-440 (2003).
51. Extermann M, Boler I, Blair J et al.: Prevalence of multiple cancers in Floridian patients aged 70 years and older. Crit. Rev. Oncol. Hematol. 60, S27 (2006).
52. Krach C: Centenarians in the United States (1990). US Census Bureau. WA, USA (1999).
53. Andersen SL, Terry DF, Wilcox MA et al.: Cancer in the oldest old. Mech. Ageing Dev. 126, 263-267 (2005).
54. Extermann M. Bernabei R, Cohen HJ et al.: Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit. Rev. Oncol. Hematol. 55(3), 241-252 (2005).
55. Surbone A, Kagawa-Singer M, Terret C, Baider L: The illness trajectory of elderly cancer patients across cultures: SIOG position paper. Ann. Oncol. (2006) (Epub ahead of print).
56. Extermann M: Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 10, 463-468 (2003).
57. Ingram SS, Seo PH, Martell RE et al.: Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J. Clin. Oncol. 20, 770-775 (2002).
58. Koroukian SM, Murray P, Madigan E: Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J. Clin. Oncol. 24, 2304-2310 (2006).
59. Flood KL, Carroll MB, Le CV, Ball L, Esker DA, Carr DB: Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J. Clin. Oncol. 24, 2298-2303 (2006).